Emerging Technologies in Clinical Laboratories as Outlined in Industrial Property Documents

Basile Spyropoulos; Manolis Kontogiorgis; Konstantinos Christou; Georgios Tzanoukos; Stella Lalissidou; Georgios Leontidis; Katerina Rota; Vassiliki Tsimpida

Emerging Technologies in Clinical Laboratories as Outlined in Industrial Property Documents

Basile Spyropoulos, Manolis Kontogiorgis, Konstantinos Christou, Georgios Tzanoukos, Stella Lalissidou, Georgios Leontidis, Katerina Rota, Vassiliki Tsimpida

Research output: Contribution to journal › Article › peer-review

20 Downloads (Pure)

Abstract

The purpose of this paper is to present in details, an extended case-study focused on emerging in vitro Diagnostics Technology as reflected on retrieved and evaluated Industrial Property Documents. More specific, this study comprises of the state-of-the-art and the perspectives of automatic Immunoassay Analyzers, it follows the innovation patent-trail from Flow Cytometry to Quantum Dots applications in the in vitro Diagnostics of tomorrow and finally, it provides an overview of the trends in Next Generation Nucleic Acid and Protein Sequencing, all of them as depicted on numerous relevant, retrieved and processed Industrial Property Documents.

Original language	English
Pages (from-to)	31-46
Number of pages	16
Journal	Electronic Journal of Science and Technology
Volume	9
Issue number	3
Publication status	Published - 2014

Keywords

IVD-Technology
Clinical Laboratories
Industrial Property Rights
Immunoassay Analyzers
Fluorescence
Quantum Dots
Next Generation Sequencing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Spyropoulos_etal_emerging_technologies_in_VOR
This journal provides immediate open access to its contents.
Final published version, 1.05 MBLicence: Other

http://ejournals.teiath.gr/index.php/ejst/article/view/798Licence: Unspecified

Cite this

@article{7f3fa98e064b4a6eb71dfd2f2d9dd11c,

title = "Emerging Technologies in Clinical Laboratories as Outlined in Industrial Property Documents",

abstract = "The purpose of this paper is to present in details, an extended case-study focused on emerging in vitro Diagnostics Technology as reflected on retrieved and evaluated Industrial Property Documents. More specific, this study comprises of the state-of-the-art and the perspectives of automatic Immunoassay Analyzers, it follows the innovation patent-trail from Flow Cytometry to Quantum Dots applications in the in vitro Diagnostics of tomorrow and finally, it provides an overview of the trends in Next Generation Nucleic Acid and Protein Sequencing, all of them as depicted on numerous relevant, retrieved and processed Industrial Property Documents.",

keywords = "IVD-Technology, Clinical Laboratories, Industrial Property Rights, Immunoassay Analyzers, Fluorescence, Quantum Dots, Next Generation Sequencing",

author = "Basile Spyropoulos and Manolis Kontogiorgis and Konstantinos Christou and Georgios Tzanoukos and Stella Lalissidou and Georgios Leontidis and Katerina Rota and Vassiliki Tsimpida",

year = "2014",

language = "English",

volume = "9",

pages = "31--46",

journal = "Electronic Journal of Science and Technology",

issn = "1790-5613",

number = "3",

}

TY - JOUR

T1 - Emerging Technologies in Clinical Laboratories as Outlined in Industrial Property Documents

AU - Spyropoulos, Basile

AU - Kontogiorgis, Manolis

AU - Christou, Konstantinos

AU - Tzanoukos, Georgios

AU - Lalissidou, Stella

AU - Leontidis, Georgios

AU - Rota, Katerina

AU - Tsimpida, Vassiliki

PY - 2014

Y1 - 2014

N2 - The purpose of this paper is to present in details, an extended case-study focused on emerging in vitro Diagnostics Technology as reflected on retrieved and evaluated Industrial Property Documents. More specific, this study comprises of the state-of-the-art and the perspectives of automatic Immunoassay Analyzers, it follows the innovation patent-trail from Flow Cytometry to Quantum Dots applications in the in vitro Diagnostics of tomorrow and finally, it provides an overview of the trends in Next Generation Nucleic Acid and Protein Sequencing, all of them as depicted on numerous relevant, retrieved and processed Industrial Property Documents.

AB - The purpose of this paper is to present in details, an extended case-study focused on emerging in vitro Diagnostics Technology as reflected on retrieved and evaluated Industrial Property Documents. More specific, this study comprises of the state-of-the-art and the perspectives of automatic Immunoassay Analyzers, it follows the innovation patent-trail from Flow Cytometry to Quantum Dots applications in the in vitro Diagnostics of tomorrow and finally, it provides an overview of the trends in Next Generation Nucleic Acid and Protein Sequencing, all of them as depicted on numerous relevant, retrieved and processed Industrial Property Documents.

KW - IVD-Technology

KW - Clinical Laboratories

KW - Industrial Property Rights

KW - Immunoassay Analyzers

KW - Fluorescence

KW - Quantum Dots

KW - Next Generation Sequencing

M3 - Article

SN - 1790-5613

VL - 9

SP - 31

EP - 46

JO - Electronic Journal of Science and Technology

JF - Electronic Journal of Science and Technology

IS - 3

ER -

Emerging Technologies in Clinical Laboratories as Outlined in Industrial Property Documents

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this